Can a mini mobility device help kids with down syndrome explore more?

NCT ID NCT06591559

First seen May 07, 2026 · Last updated Jun 20, 2026 · Updated 11 times

Summary

This study looked at how young children with Down syndrome, cerebral palsy, and other motor delays move and explore when using a powered mobility device called the Explorer Mini and a bodyweight support system. Sixteen children who could sit upright but not walk 10 feet on their own took part. Researchers measured how much of the play space they explored and their muscle activity during play.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Washington

    Seattle, Washington, 98195, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Permobil Explorer Mini (powered mobility device) and overground partial bodyweight support system

What this could lead to

If successful, this could help design better mobility aids and therapies for young children with developmental delays, improving their independence and exploration.

What could go wrong

This is a very small, completed observational study with only 16 children. Results may not apply to all children with these conditions, and the devices may not work for everyone.

Conditions

The condition(s) this trial relates to.

cerebral palsy Down syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.